|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo~controlled study 显示文摘 | Uhl W NoIting A Golor G | 2006 | Clin Toxicol(Phila)2006，44，1： | 1 |
| 2 | Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes显示文摘 | Gary A. Herman Arthur Bergman Catherine Stevens Paul Kotey Bingming Yi Peng Zhao Bruno Dietrich George Golor Andreas Schrodter Bart Keymeulen Kenneth C. Lasseter Mark S. Kipnes Karen Snyder Deborah Hilliard Michael Tanen Caroline Cilissen Marina De Smet I | 2006 | The Journal of Clinical Endocrinology & Metabolism2006，，11： | 1 |
| 3 | An open-label, parallel group study investigating the effects of age and gender on the pharmacokinetics of the once-daily glucagon-like peptide-1 analogue liraglutide显示文摘 | Damholt B Golor G Wierich W | 2006 | J Clin Pharmacol2006，46，6： | 1 |
| 4 | Clinical pharmacokinetics of alamifovir and its metabolites显示文摘 | Chan C Abu-Raddad E Golor G | | 0，，05： | 1 |
| 5 | Comparison of the kinetics of clorinated and brominated dioxins and furans in the rat显示文摘 | YAMASHITA K MCLACHLAN M HCTZINGER O NEUBERT D | 1993 | Organohalogen Compounds1993，12，： | 1 |
| 6 | Quantum Monte Carlo studies of edge magnetism in chiral graphene nanoribbons 显示文摘 | GOLOR M LANG T C WESSEL S | 2013 | Physical Review B2013，87，15： | 1 |
| 7 | A first-in-man study to evaluate the safety,tolerability,and pharmacokinetics of pasireotide (SOM230),a multireceptor-targeted somatostatin analog,in healthy volunteers显示文摘 | Golor G Hu K Ruffin M | 2012 | Drug Des Devel Ther2012，6，： | 1 |
| 8 | A first-in-man study to evaluate the safety,tolerability,and pharmacokinetics of pasireotide(SOM230),a multireceptor-targeted somatostatin analog,in healthy volunteers显示文摘 | Golor G Hu K Ruffin M | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员